PC08.02 Debate #1: Locally Ablative Therapies Should Be Standard Treatment for Patients With NSCLC Oligometastese (CON)
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.115
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV